Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trafficking protein particle complex 13 pseudogene 1 (TRAPPC13P1) is annotated as a pseudogene based on current databases for Homo sapiens. Unlike protein-coding genes or established drug targets, pseudogenes do not code for functional proteins, and there is no evidence for either a functional protein product or disease relevance. TRAPPC13P1 should not be considered a canonical therapeutic target, enzyme, transporter, receptor, or gene with known physiological function. Its primary association is with sequence homology to the functional TRAPPC13 gene, a known subunit of the TRAPPIII complex involved in intracellular protein trafficking and autophagy[4][7]. TRAPPC13P1 is cataloged as a pseudogene in major human genetics databases, including BioGPS and Bgee, with no confirmed expression or function reported[4][7]. Unlike TRAPPC13, which is a functional subunit of the TRAPPIII complex important for autophagic flux and has disease associations, TRAPPC13P1 itself is non-coding and not involved in these cellular or disease pathways[3]. There is no evidence of TRAPPC13P1 being a therapeutic target, nor any data linking it to drug interactions, biomarkers, or safety concerns. Use caution: If the intent was to reference the functional TRAPPC13 protein (not the pseudogene), significantly different answers would apply, as TRAPPC13 is implicated in intracellular trafficking and some cardiovascular and heart-related phenotypes[3]. In summary, TRAPPC13P1 is a pseudogene with no known protein product, biological function, or disease association, and it should not be considered a valid therapeutic target[4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trafficking protein particle complex 13 pseudogene 1 (TRAPPC13P1).